Effect, Tolerability, and Safety of Exclusive Palatable Elemental Diet in Patients With Intestinal Microbial Overgrowth
Clinical Gastroenterology and Hepatology · 2025-11 · 23 (12) · 2306-2317.e7
DOI: 10.1016/j.cgh.2025.03.002 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025-11. Verfasst von Ali Rezaie und 18 weiteren Autor:innen. Beteiligte Einrichtung: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California; Karsh Division of Gastroenterology and Hepatology,…. Hauptthemen laut MEDLINE: Food, Formulated, Gastrointestinal Microbiome. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bausch Health.
Abstract (Originalsprache)
BACKGROUND & AIMS: Elemental diets (EDs) have desirable safety and efficacy profiles in several clinical settings partly because of modulation of gut microbiome. Palatability of EDs remains the main barrier to compliance/adherence, and their effect has not been prospectively explored in microbiome-driven disorders, such as small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO). We aimed to assess the effect, tolerance, and safety of a novel palatable ED (PED) in subjects with IMO and/or SIBO. METHODS: Adult subjects with positive lactulose breath tests for SIBO and/or IMO completed 1 week of screening, 2 weeks of exclusive oral PED, and 2 weeks of follow-up during reintroduction of regular diet. Primary end point was changes in stool microbiome after PED and reintroduction of regular diet. Secondary end points included tolerability, rate of normalization of lactulose breath tests, change in stool form based on daily diary and artificial intelligence-analyzed images, symptomatic response, and adverse events. RESULTS: All 30 enrolled subjects tolerated the PED and completed the trial. Several taxonomic differences were detected including decreased relative abundance of Prevotella_9 and Fusobacterium. Abundance of Methanobrevibacter smithii decreased at the end of the trial and correlated with average daily methane levels (P = .024; r = 0.489). Maximum methane levels (41 ± 35 to 12 ± 15 ppm; P < .001) and hydrogen rise (43 ± 42 to 12 ± 11 ppm; P < .001) dropped significantly, with 73% normalizing their lactulose breath tests. Adequate global relief of symptoms was reported in 83% of subjects. No serious or severe adverse events were observed. CONCLUSIONS: PED significantly impacts the gut microbiome. Tolerance to EDs improves with enhanced palatability. Larger studies with longer follow-up are needed to assess response durability. (ClinicalTrials.gov ID: NCT05978973).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California; Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai, Los Angeles, California. Electr…
- Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai, Los Angeles, California.
- Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California.
- Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Cedars-Sinai, Los Angeles, California.
- mBiota Elemental, Santa Monica, California.
- Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California; Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai, Los Angeles, California.
Förderung
- Bausch Health
Zitieren
APA
Rezaie, A., Chang, B. W., de Freitas Germano, J., Leite, G., Mathur, R., Houser, K., Hosseini, A., Brimberry, D., Rashid, M., Mehravar, S., Villanueva-Millan, M. J., Sanchez, M., Weitsman, S., Fajardo, C. M., Rivera, I. G., Joo, L., Chan, Y., Barlow, G. M., & Pimentel, M. (2025). Effect, Tolerability, and Safety of Exclusive Palatable Elemental Diet in Patients With Intestinal Microbial Overgrowth. Clinical Gastroenterology and Hepatology, 23(12), 2306-2317.e7. https://doi.org/10.1016/j.cgh.2025.03.002
Vancouver
Rezaie A, Chang BW, de Freitas Germano J, Leite G, Mathur R, Houser K, et al. Effect, Tolerability, and Safety of Exclusive Palatable Elemental Diet in Patients With Intestinal Microbial Overgrowth. Clinical Gastroenterology and Hepatology. 2025;23(12):2306-2317.e7. doi:10.1016/j.cgh.2025.03.002
BibTeX
@article{Rezaie2025,
author = {Rezaie, Ali and Chang, Bianca W and de Freitas Germano, Juliana and Leite, Gabriela and Mathur, Ruchi and Houser, Krystyna and Hosseini, Ava and Brimberry, Daniel and Rashid, Mohamad and Mehravar, Sepideh and Villanueva-Millan, Maria Jesus and Sanchez, Maritza and Weitsman, Stacy and Fajardo, Cristina M and Rivera, Ignacio G and Joo, Lijin and Chan, Yin and Barlow, Gillian M and Pimentel, Mark},
title = {Effect, Tolerability, and Safety of Exclusive Palatable Elemental Diet in Patients With Intestinal Microbial Overgrowth},
journal = {Clinical Gastroenterology and Hepatology},
year = {2025},
volume = {23},
number = {12},
pages = {2306--2317.e7},
doi = {10.1016/j.cgh.2025.03.002}
}
EUVIMED